Evaluation of Markers and Risk Prediction Models: Overview of Relationships between NRI and Decision-Analytic Measures
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background. For the evaluation and comparison of markers and risk prediction models, various novel measures have recently been introduced as alternatives to the commonly used difference in the area under the receiver operating characteristic (ROC) curve (ΔAUC). The net reclassification improvement (NRI) is increasingly popular to compare predictions with 1 or more risk thresholds, but decision-analytic approaches have also been proposed. Objective. We aimed to identify the mathematical relationships between novel performance measures for the situation that a single risk threshold T is used to classify patients as having the outcome or not. Methods. We considered the NRI and 3 utility-based measures that take misclassification costs into account: difference in net benefit (ΔNB), difference in relative utility (ΔRU), and weighted NRI (wNRI). We illustrate the behavior of these measures in 1938 women suspect of having ovarian cancer (prevalence 28%). Results. The 3 utility-based measures appear to be transformations of each other and hence always lead to consistent conclusions. On the other hand, conclusions may differ when using the standard NRI, depending on the adopted risk threshold T, prevalence P, and the obtained differences in sensitivity and specificity of the 2 models that are compared. In the case study, adding the CA-125 tumor marker to a baseline set of covariates yielded a negative NRI yet a positive value for the utility-based measures. Conclusions. The decision-analytic measures are each appropriate to indicate the clinical usefulness of an added marker or compare prediction models since these measures each reflect misclassification costs. This is of practical importance as these measures may thus adjust conclusions based on purely statistical measures. A range of risk thresholds should be considered in applying these measures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decision curve analysis: a novel method for evaluating prediction models
Vickers, A. J., & Elkin, E. B. (2006) · Medical Decision Making · doi:10.1177/0272989x06295361 · Cited by 6,341 · cited 4×
“Therefore, as a sensitivity analysis, the performance of prediction rules should be reported for different values of T.(13,17)”
BackgroundMethodSelf-citationAssessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Self-citationClinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
Self-citationSteyerberg, E. W. (2009) · Statistics for Biology and Health · doi:10.1007/978-0-387-77244-8 · Cited by 1,491
Self-citationReilly, B. M., & Evans, A. T. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-3-200602070-00009 · Cited by 794
Assessing the incremental value of diagnostic and prognostic markers: a review and illustration
Steyerberg, E. W., Pencina, M. J., Lingsma, H. F., Kattan, M. W., Vickers, A. J., & Van Calster, B. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02562.x · Cited by 219 · cited 1×
“The incremental value of a new marker would then be assessed by the difference in AUCs (DAUC) for a model with the marker as a predictor variable and a model without.(6,7) However, it is widely recognized that more advanced measures than AUC and DAUC are needed.”
MethodSelf-citationUsing Relative Utility Curves to Evaluate Risk Prediction
Baker, S. G., Cook, N. R., Vickers, A., & Kramer, B. S. (2009) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2009.00592.x · Cited by 142
Self-citation
Cited by
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, G. S. (2015) · Annals of Internal Medicine · doi:10.7326/m14-0698 · Cited by 5,147
Self-citationTowards better clinical prediction models: seven steps for development and an ABCD for validation
Steyerberg, E. W., & Vergouwe, Y. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu207 · Cited by 1,928
Self-citationReporting and Interpreting Decision Curve Analysis: A Guide for Investigators
Van Calster, B., Wynants, L., Verbeek, J. F. M., Verbakel, J. Y., Christodoulou, E., Vickers, A. J., Roobol, M. J., & Steyerberg, E. W. (2018) · European Urology · doi:10.1016/j.eururo.2018.08.038 · Cited by 1,271
Self-citationVickers, A. J., Van Calster, B., & Steyerberg, E. W. (2016) · BMJ · doi:10.1136/bmj.i6 · Cited by 1,163
Self-citationA calibration hierarchy for risk models was defined: from utopia to empirical data
Van Calster, B., Nieboer, D., Vergouwe, Y., De Cock, B., Pencina, M. J., & Steyerberg, E. W. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.12.005 · Cited by 910
Self-citation
Metadata
- Authors
- Van Calster, B., Vickers, A. J., Pencina, M. J., Baker, S. G., Timmerman, D., & Steyerberg, E. W.
- Venue
- Medical Decision Making
- Publisher
- SAGE Publications
- Published
- 2013-01-11
- Volume
- 33
- Issue
- 4
- Pages
- 490-501
- ISSN
- 0272-989X (ISSN-L)
- 1552-681X
- OpenAlex
- W2024583141
- Cited by
- 76
- References
- 7
- FWCI
- 8.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of Markers and Risk Prediction Models: Overview of Relationships between NRI and Decision-Analytic Measures. https://app.cochat.ai/papers/10.1177/0272989x12470757
- The paper
- Van Calster, B., Vickers, A. J., Pencina, M. J., Baker, S. G., Timmerman, D., & Steyerberg, E. W. (2013). Evaluation of Markers and Risk Prediction Models: Overview of Relationships between NRI and Decision-Analytic Measures. Medical Decision Making. https://doi.org/10.1177/0272989x12470757
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.